Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

D Fax Plus 50mg/0.5mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Alteus Biogenics Pvt Ltd

Salt Composition

Desvenlafaxine (50mg) + Clonazepam (0.5mg)

Overview D Fax Plus 50mg/0.5mg Tablet ER

Combiflex 50mg/0.5mg Extended-Release Tablets treat depression by combining two active ingredients to boost brain chemicals promoting calmness and nerve relaxation. This medication can be taken with or without food, ideally at the same time daily for consistent blood levels. Follow your doctor's prescribed dosage and duration; if a dose is missed, take it immediately upon recall. Complete the entire course, even if feeling improved, and never discontinue use abruptly without consulting your physician, as this could exacerbate symptoms. Potential side effects include nausea, constipation, cognitive impairment (confusion, memory issues), insomnia, headache, sexual dysfunction (reduced libido, erectile dysfunction, ejaculatory problems), fatigue, and ataxia (uncoordinated movements). Dizziness and drowsiness may occur; avoid driving or activities requiring alertness until the medication's effects are known. These side effects are usually transient. Report persistent or bothersome symptoms to your doctor. Prior to starting treatment, disclose any pre-existing conditions like thyroid or kidney disease, epilepsy, Parkinson's disease, glaucoma, or heart problems. Concurrently using alcohol, sedatives, cough suppressants, or antihistamines is contraindicated. Alcohol should be avoided while taking Combiflex 50mg/0.5mg ER as it may intensify some side effects.

Primary Ingredients of D Fax Plus 50mg/0.5mg Tablet ER

No text was provided to rephrase. Please provide the text you wish to have rewritten.

Uses of D Fax Plus 50mg/0.5mg Tablet ER

Managing Depressive Disorders

Major Benefits of D Fax Plus 50mg/0.5mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not attempt to crush, chew, or divide it. D Fax Plus 50mg/0.5mg Extended-Release Tablets can be administered with or without food, however, consistent timing is recommended.

Common Side effects of D Fax Plus 50mg/0.5mg Tablet ER:

  • Nausea
  • Constipation
  • Confusion
  • Insomnia (difficulty in sleeping)
  • Memory impairment
  • Headache
  • Ejaculation disorder
  • Tiredness
  • Erectile dysfunction
  • Low sexual desire
  • Uncoordinated body movements
  • Depression

How to use D Fax Plus 50mg/0.5mg Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. D Fax Plus 50mg/0.5mg Extended-Release Tablets may be consumed with or without food, however, consistent timing is recommended.

How D Fax Plus 50mg/0.5mg Tablet ER works:

Extended-release D Fax Plus tablets (50mg/0.5mg) contain a dual-medication formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and D Fax Plus 50mg/0.5mg Extended-Release tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release D Fax Plus 50mg/0.5mg tablets are contraindicated during pregnancy due to established fetal risks. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release D Fax Plus 50mg/0.5mg tablets are likely not safe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Extended-release D Fax Plus 50mg/0.5mg tablets may impair driving ability due to potential side effects.

KidneyKidneySAFE IF PRESCRIBED

The extended-release D Fax Plus 50mg/0.5mg tablet is likely safe for individuals with kidney impairment. Preliminary evidence indicates dose modification may be unnecessary in such cases. However, physician consultation is advised. Patients with end-stage renal disease may experience increased drowsiness when taking D Fax Plus 50mg/0.5mg extended-release tablets.

LiverLiverCAUTION

Patients with hepatic impairment should use D Fax Plus 50mg/0.5mg Extended-Release tablets cautiously. Dosage modification of D Fax Plus 50mg/0.5mg Extended-Release tablets may be necessary. Physician consultation is advised.

What if you forget to take D Fax Plus 50mg/0.5mg Tablet ER :

Should you forget a D Fax Plus 50mg/0.5mg Extended-Release Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About D Fax Plus 50mg/0.5mg Tablet ER

LabelValue
Potential for Dependence Affirmative.
Type of Medication Nervous system medications

FAQs on D Fax Plus 50mg/0.5mg Tablet ER

In the initial stages of D Fax Plus 50mg/0.5mg Tablet ER therapy, some individuals may experience intensified suicidal ideation or behavior. This risk is heightened for patients with pre-existing mood or behavioral disturbances. Prompt reporting of any such changes in mood or behavior to your physician is crucial. Regular attendance at scheduled follow-up appointments is also essential.
Discontinue D Fax Plus 50mg/0.5mg Tablet ER only under your physician's guidance. Abrupt cessation may result in severe withdrawal effects; therefore, continued use, even with symptom improvement, is advised. Your doctor will likely implement a gradual dose reduction.
Some patients taking D Fax Plus 50mg/0.5mg Extended-Release Tablets have reported weight increase. Maintaining a healthy diet and regular physical activity may mitigate this effect. Preventing weight gain is simpler than subsequent weight loss.
D Fax Plus 50mg/0.5mg Extended-Release tablets may cause drowsiness. Refrain from driving, operating equipment, working at heights, or engaging in hazardous activities until you understand the drug's effects on you.
Taking D Fax Plus 50mg/0.5mg Extended-Release Tablets may lead to sexual side effects in males and females. Reduced libido, erectile dysfunction (difficulty achieving or sustaining an erection), and anorgasmia (inability to achieve orgasm) are frequently reported. Decreased sexual satisfaction and discomfort during intercourse are also possible. Consult your physician if you encounter such issues.
Refrain from consuming alcohol during your D Fax Plus 50mg/0.5mg Tablet ER treatment. Alcohol may worsen the drowsiness or sleepiness this medication can cause.
Individual responses to this therapy vary. Typically, experiencing the complete effects of D Fax Plus 50mg/0.5mg Tablet ER requires several weeks, though some individuals notice improvement earlier. Patience is key when using D Fax Plus 50mg/0.5mg Tablet ER, allowing sufficient time for its action.
Retain this medication within its original, sealed packaging. Follow the storage guidelines provided on the package or label. Discard any leftover medication. Prevent access by children, pets, and others.
D Fax Plus 50mg/0.5mg Tab...
234
MRP 286
18% off